Production (Stage)
Utah Medical Products, Inc.
UTMD
$53.76
$0.100.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.13% | -32.29% | -9.45% | -17.79% | -6.12% |
| Total Depreciation and Amortization | 5.56% | -29.81% | -58.54% | -61.05% | -61.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.43% | 139.23% | 100.00% | -2.88% | -324.00% |
| Change in Net Operating Assets | 11.88% | -340.00% | 11.13% | -32.74% | -15.56% |
| Cash from Operations | -15.39% | -44.92% | -24.70% | -43.78% | -23.70% |
| Capital Expenditure | -736.36% | 90.00% | 52.15% | 65.63% | 48.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3,780.00% | 90.00% | 52.15% | 64.06% | 111.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | 390.00% | 357.14% |
| Repurchase of Common Stock | -7.73% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 6.61% | 3.08% | 1.77% | -1.03% | -1.78% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -6.40% | -623.34% | -375.17% | -611.88% | -279.69% |
| Foreign Exchange rate Adjustments | 185.75% | -234.63% | 223.87% | -137.10% | -1,067.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -62.87% | -217.54% | -121.36% | -223.79% | -83.96% |